SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Galena Biopharma, Inc.

( )
GALE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading GALE News...
Health Technology » Biotechnology
GILDGilead Sciences, Inc.
AMGNAmgen Inc.
BIIBBiogen Inc.
CELGCelgene Corporation
ILMNIllumina, Inc.
REGNRegeneron Pharmaceuticals, Inc.
SRPTSarepta Therapeutics, Inc.
ALXNAlexion Pharmaceuticals, Inc.
VRTXVertex Pharmaceuticals Incorporated
INCYIncyte Corporation
CLVSClovis Oncology, Inc.
EXELExelixis, Inc.
BMRNBioMarin Pharmaceutical Inc.

Company Profile

Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs. It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral (fentanyl) sublingual tablets and Zuplenz (ondansetron) oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.